Dietary Fatty Acid Modification for the Treatment of Aspirin-Exacerbated Respiratory Disease: A Prospective Pilot Trial
Schneider T, Johns C, Palumbo M, Murphy K, Cahill K, Laidlaw T. Dietary Fatty Acid Modification for the Treatment of Aspirin-Exacerbated Respiratory Disease: A Prospective Pilot Trial. The Journal Of Allergy And Clinical Immunology In Practice 2017, 6: 825-831. PMID: 29133219, PMCID: PMC5945343, DOI: 10.1016/j.jaip.2017.10.011.Peer-Reviewed Original ResearchConceptsAspirin-exacerbated respiratory diseaseUrinary leukotriene EDietary interventionLeukotriene ERespiratory diseaseTreatment of AERDDietary fatty acid modificationAsthma Control Questionnaire scoreNasal Outcome Test (SNOT-22) scoresAdjunct treatment optionProspective pilot trialPatient-reported questionnaireFatty acid consumptionTreatment of aspirinOutcome Test scoresAdult patientsAdverse eventsLung functionPrimary outcomeClinical efficacyVital capacityTreatment optionsWomen's HospitalIntervention periodPilot trial